AtriCure, Inc. (ATRC) vs Neogen Corporation (NEOG)
A side-by-side comparison of AtriCure, Inc. and Neogen Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ATRC
AtriCure, Inc.
$54.88HealthcareDelayed quote: Oct 6, 2026, 12:45 PM EDT
NEOG
Neogen Corporation
$12.14HealthcareDelayed quote: Oct 6, 2026, 12:40 PM EDT
Total return — ATRC vs NEOG
growth of $100 · dividends reinvested · last 10yATRC +224.3% (+12.5%/yr)NEOG -37.4% (-4.6%/yr)ATRC compounded faster over this window
Log scale — wide-divergence pair
ATRC NEOG
ATRC vs NEOG: by the numbers
- •ATRC is the larger company ($2.79B vs $2.65B market cap).
- •ATRC is profitable (1.85% net margin) while NEOG runs a net loss (-0.91%).
- •ATRC grew revenue faster over the past five years (18.57% vs 13.19% CAGR).
Metrics side by side
Valuation
| Metric | ATRC | NEOG |
|---|---|---|
| P/E ratio | 258.60 | N/A |
| Forward P/E | N/A | 39.16 |
| P/S ratio | 4.90 | 3.04 |
| P/B ratio | 5.40 | 1.26 |
| EV / EBITDA | 77.55 | 32.47 |
| FCF yield | 1.84% | N/A |
Profitability
| Metric | ATRC | NEOG |
|---|---|---|
| Gross margin | 76.16% | 46.93% |
| Operating margin | 2.44% | -2.49% |
| Net margin | 1.85% | -0.91% |
| ROE | 2.04% | -0.38% |
| ROIC | 2.04% | -0.68% |
Growth (annualized)
| Metric | ATRC | NEOG |
|---|---|---|
| Revenue CAGR (5Y) | 18.57% | 13.19% |
| Total return CAGR (5Y) | -4.06% | -21.13% |
Frequently asked
- Which has grown faster, ATRC or NEOG?
- Over the past five years, ATRC grew revenue faster — ATRC at a 18.57% CAGR versus NEOG at 13.19%.
- Is ATRC or NEOG more profitable?
- ATRC runs the higher net margin — ATRC at 1.85% versus NEOG at -0.91%.
- How have ATRC and NEOG total returns compared?
- Over the past 10 years, ATRC delivered 13.44% and NEOG delivered -4.56% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AtriCure P/E ratioAtriCure ROENeogen ROEAtriCure operating marginNeogen operating marginAtriCure revenue growthNeogen revenue growthAtriCure free cash flowNeogen free cash flow
AtriCure & Neogen appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.